Insulet Corporation - Common Stock (PODD)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 275% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 18.2% — good return on equity
- Revenue growing at 31% annually
Insulet Corporation - Common Stock (PODD) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $9.9 billion . Key value metrics: P/E ratio 41.7, P/B ratio 7.57, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Insulet Corporation - Common Stock — Fundamental Analysis Summary
Insulet Corporation - Common Stock (PODD) is currently trading 275% above its Graham Number of $38.02, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 41.7x.
On financial health, PODD shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and solid return on equity of 18.2% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 2.29.
StockPik's composite Value Score for PODD is 56/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PODD reports a high gross margin of 70.7% (sector average: 39.4%) and a solid operating margin of 16.7%.
PODD shows revenue growing at 31% year-over-year, with earnings declining at 41%.